| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
794 |
731 |
$104K |
| 99205 |
Prolong outpt/office vis |
1,111 |
1,102 |
$99K |
| 99215 |
Prolong outpt/office vis |
1,720 |
1,548 |
$90K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
609 |
574 |
$20K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
82 |
79 |
$11K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
618 |
537 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
230 |
218 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
349 |
335 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
421 |
410 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
170 |
169 |
$777.10 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
36 |
34 |
$362.48 |
| 94760 |
|
371 |
333 |
$355.69 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
55 |
54 |
$253.86 |
| 87400 |
|
26 |
13 |
$115.80 |
| 81003 |
|
40 |
40 |
$49.02 |